Alexion Pharmaceuticals, Inc. ALXN
$ 182.5
0.0%
Alexion Pharmaceuticals, Inc. Income Statement 2011-2024 | ALXN
Annual Income Statement Alexion Pharmaceuticals, Inc.
2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
33.6 B | 22.4 B | 27 B | 27.4 B | 28.7 B | 31.1 B | 36.3 B | 31.7 B | 18.2 B | 13.7 B |
Shares |
219 M | 223 M | 223 M | 224 M | 224 M | 213 M | 198 M | 196 M | 190 M | 183 M |
Net Income |
603 M | 2.4 B | 77.6 M | 443 M | 399 M | 144 M | 657 M | 253 M | 255 M | 175 M |
Revenue |
6.07 B | 4.99 B | 4.13 B | 3.55 B | 3.08 B | 2.6 B | 2.23 B | 1.55 B | 1.13 B | 783 M |
EBITDA |
3.11 B | 2.45 B | 1.91 B | 1.12 B | 1.12 B | 799 M | 963 M | 567 M | 454 M | 245 M |
Operating Expenses |
2.66 B | 2.46 B | 2.16 B | 2.29 B | 2.03 B | 1.69 B | 1.14 B | 807 M | 608 M | 446 M |
General and Administrative Expenses |
1.4 B | 1.26 B | 1.11 B | 1.09 B | 954 M | 863 M | 630 M | 490 M | 385 M | 308 M |
All numbers in USD currency